Acridine-9-carboxylic acid xhydrate

Catalog No.: 
ACPZQB610
CAS No.: 
332927-03-4
Molecular Formula: 
C14H9NO2.xH2O
Molecular Weight: 
241.25
Acridine-9-carboxylic acid xhydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$73.00In stockIn stock
100g97%$283.00In stockIn stock
500g97%$1375.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAcridine-9-carboxylic acid xhydrate
IUPAC Nameacridine-9-carboxylic acid hydrate
MDL No.MFCD00149578
Molecular FormulaC14H9NO2.xH2O
Molecular Weight241.25
SMILESO=C(C1=C(C=CC=C2)C2=NC3=CC=CC=C31)O.[H]O[H]
InChI KeyZQAZWHSZYVXGMP-UHFFFAOYSA-N
SynonymAcridine-9-carboxylic acid xhydrate | SCHEMBL2991911 | FT-0661409 | ZQAZWHSZYVXGMP-UHFFFAOYSA-N | Acridine-9-carboxylic acid hydrate | FT-0775073 | SY029727 | MFCD00149578 | Acridine-9-carboxylicacidxhydrate | 9-Acridinecarboxylic acid hydrate, 97% | acri
CAS No.332927-03-4
PubChem CID16211687

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPZQB610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGJVZ329 route compound structure diagram
    ACGJVZ3295132-81-0In Stock
  2. Then
  3. ACPZQB610 route product structure diagram
    ACPZQB610332927-03-4In Stock
Inquiry

2. ACPZQB610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPZQB610 route product structure diagram
    ACPZQB610332927-03-4In Stock
Inquiry

3. ACPZQB610 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPZQB610 route product structure diagram
    ACPZQB610332927-03-4In Stock
Inquiry

Comments (0)